Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study

Current Cancer Drug Targets
Irina R GilyazovaGjumrakch Aliev

Abstract

Renal cell carcinoma represents 3% of all adult malignancies. MicroRNAs exhibit specific functions in various biological processes through their interaction with cellular mRNA involved in apoptosis and cell cycle control. Recent studies have reported the potential association of single-nucleotide polymorphisms (SNPs) in miRNA-binding sites of VHL-HIF1α pathway genes with renal cancer development and progression. The objective of this study is to investigate SNPs invoking an alteration in the nature of interaction with miRNA binding sites of VHL-HIF1α pathway genes. Total 450 cases of histologically and clinically verified ccRCC and 490 controls were included in our study. Genotyping was performed using a TaqMan PCR allelic discrimination method. Kaplan-Meier method of statistical analysis was implemented to analyze the overall patient survival rate. Polymorphism rs10491534 in TSC1 gene was significantly associated with risk of developing advanced ccRCC. Allele G of rs1642742 in VHL gene was significantly prevalent in ccRCC compared with control group aged 55 and older (OR = 1.5566; CI [1.1532-2.1019]). Results from the dominant model combining individuals with AG or AA genotype showed that the A allele bearers of CDCP1 rs677357...Continue Reading

References

Nov 4, 2004·International Journal of Cancer. Journal International Du Cancer·Jay D HuntPaul Brennan
Oct 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Harlan Robins, William H Press
Dec 22, 2007·Expert Review of Anticancer Therapy·W Kimryn Rathmell, Shufen Chen
Dec 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yohei HorikawaXifeng Wu
Sep 19, 2009·Nature Reviews. Genetics·Carlo M Croce
Jul 27, 2010·Breast Cancer Research and Treatment·Madhura S MehtaKim M Hirshfield
Jan 15, 2011·Proceedings of the National Academy of Sciences of the United States of America·Olga V RazorenovaAmato J Giaccia
Oct 15, 2011·PLoS Genetics·Claes OhlssonRobin Haring
Nov 25, 2011·Cancer Biomarkers : Section a of Disease Markers·Paul Cairns
Apr 21, 2012·Molecular Carcinogenesis·Hua WeiMichelle A T Hildebrandt
May 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michelle A T HildebrandtXifeng Wu
Sep 29, 2012·BMC Medicine·Naveen S VasudevRosamonde E Banks
Feb 5, 2013·Proceedings of the National Academy of Sciences of the United States of America·Brooke M EmerlingLewis C Cantley
Feb 11, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Peng SongQinghong Zhao
Feb 11, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ting ZhongYun Chen
Dec 30, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hongliang LiuZhensheng Liu
May 20, 2016·Cold Spring Harbor Perspectives in Biology·Stephen B Baylin, Peter A Jones
Sep 22, 2016·Expert Review of Molecular Diagnostics·Jörg EllingerDimo Dietrich
Sep 25, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EscudierUNKNOWN ESMO Guidelines Committee
Oct 16, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel H LiYuan Ji
Jun 7, 2017·Physical Biology·Davide Cora'Federico Bussolino
May 31, 2018·Non-coding RNA·Almudena Expósito-VillénDiego Franco
Aug 3, 2018·Journal of Cellular Physiology·Nasser H GoradelAmirhossein Sahebkar

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis